Hospital and Internal Medicine Podcast

Hospital and Internal Medicine Podcast

Gil Porat, M.D., FACP, CPT

Intended for the medical professional who enjoys learning for the sake of it. Dr. Porat is a practicing Colorado Hospitalist and Board Certified in Internal Medicine.

Categories: Health

Listen to the last episode:

The double-blind, randomized phase III EMPEROR-Preserved trial showed a benefit of the sodium-glucose cotransporter-2 (SGLT2) inhibitor empagliflozin in patients with heart failure with preserved ejection fraction (HFpEF). Now let us dig a bit more into those headlines.

Previous episodes

  • 233 - Heart Failure with Preserved Ejection Fraction (Diastolic CHF) and SGLT-2 Inhibitor Therapy 
    Thu, 27 Jan 2022 - 0h
  • 232 - Should You Postpone Interventions for INFECTED Necrotizing Pancreatitis? 
    Mon, 18 Oct 2021 - 0h
  • 231 - Spontaneous Bacterial Peritonitis - Unique Infections in Cirrhosis part 2 
    Sun, 27 Jun 2021 - 0h
  • 230 - Unique Infectious Considerations in Cirrhosis - part 1 
    Tue, 15 Jun 2021 - 0h
  • 229 - Gastric Emptying Abnormalities - Part 2 
    Sat, 08 May 2021 - 0h
Show more episodes

More Nigeria health podcasts

More international health podcasts

Choose podcast genre